Clinical Trial Update: Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for S-588410 after adjuvant chemotherapy in completely resected non-small cell lung cancer (NSCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-588410

Snippet

Sponsor: Tokyo University | Conditions: Non-small- Cell Lung Cancer | Phase 2 | Status: UNKNOWN